Skip to content

Glooko Launches EndoTool IV Cloud for Diabetes Management

Glooko, Inc. has launched Glooko EndoTool IV Cloud, an FDA 510(k)-cleared SaaS solution for inpatient IV insulin dosing, designed to enhance glycemic management in hospitals through patient-specific clinical intelligence.

PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum, today announced the commercial launch of Glooko EndoTool IV Cloud, its FDA 510(k)-cleared, SaaS-based inpatient IV insulin dosing solution. Glooko EndoTool IV Cloud combines EndoTool’s established patient-specific clinical intelligence with a modern clinical experience and cloud archite